CLOs on the Move

NNE Pharmaplan NA

www.nnepharmaplan.com

 
NNE Pharmaplan is the world's leading engineering and consultancy company focused entirely on the pharma and biotech industries. We employ more than 1500 people world-wide and offer global reach and local knowledge along with our all-encompassing list of
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Medical Services of America

Medical Services of America is a comprehensive home healthcare provider that offers home healthcare, hospice care, home medical equipment. Our home healthcare services allow you or your loved one to continue to live independently at home. We provide co...

Happify Health

Happify Health designs and deploys highly engaging software that can improve mental health, physical health, and well-being across the continuum of care. And we bring all sides of healthcare together, in partnership with leading enterprises, pharma, health plans, and healthcare clients around the world.

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.

Kolltan

Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.

MedPoint Communications

MedPoint Communications, Inc is a Evanston, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.